FindTrial
Sign In

To compare the efficacy and safety of tinted and non-tinted sunscreen in topical steroid damaged face.

Efficacy and safety of tinted vs non-tinted sunscreen use in topical steroid damaged face (TSDF): A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106639
Enrollment
70
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

Intervention1: Tinted Sunscreen: Tinted Sunscreen Local application (full face) BD in morning for 2 months Control Intervention1: Non-tinted Sunscreen: Non-tinted Sunscreen Local application (full fac

Sponsors

ATUL KEJARIWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: history of topical steroid use for more than 1 month

Exclusion criteria

Exclusion criteria: 1. systemic corticosteroid use within the last 1 month 2. pregnant or lactating females

Design outcomes

Primary

MeasureTime frame
Change in Dermoscopy-Assisted Topical Steroid-Damaged Face Severity (DATS) score from baseline to 8 weeks between the two groups.Timepoint: 0, 4 and 8 weeks—

Secondary

MeasureTime frame
1.Change in Physician Global Assessment (PGA) score from baseline to 8 weeks 2. Change in Dermatology Life Quality Index (DLQI) from baseline to 8 weeks. 3. Clinical and dermoscopic photographic improvement at 4 and 8 weeks compared to baseline.Timepoint: 0 and 8 weeks—

Countries

India

Contacts

Public ContactLAXMAN BESRA

KALINGA INSTITUTE OF MEDICAL SCIENCES,BHUBANESHWAR,ORISSA

laxman.derm@gmail.com9500282040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026